A phase I, randomized, double‐blind study to assess the...

  • Main
  • 2020 / 08
  • A phase I, randomized, double‐blind study to assess the...
Clinical and Experimental Dermatology 2020 / 08

A phase I, randomized, double‐blind study to assess the safety, tolerability, and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis

Berstein, G., Zhang, Y., Berger, Z., Kieras, E., Li, G., Samuel, A., Yeoh, T., Dowty, H., Beaumont, K., Wigger‐Alberti, W., von Mackensen, Y., Kroencke, U., Hamscho, R., Garcet, S., Krueger, J.G., B
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical and Experimental Dermatology
DOI:
10.1111/ced.14412
Date:
August, 2020
File:
PDF, 8.06 MB
2020
Conversion to is in progress
Conversion to is failed